Tyrosine kinase inhibitors, also known as TKIs, have been the first-line standard of care for advanced or metastatic renal cell carcinoma for over a decade. Join our 'TKIs for Renal Cell Carcinoma' Patient Education series, in which we explore what they are, how they work, and how to maintain quality of life during TKI treatment.
